“…As an innovative approach, the drugs in the class II–IV of the biopharmaceutical classification system (BCS) have been incorporated into electrospun nanofibrous webs of hydrophilic polymers for developing ODDSs. For this purpose, the nanofibrous webs of polyvinylpyrrolidone (PVP), − polyvinyl alcohol (PVA), Eudragit, gelatin, the polymer blends of PVP/PVA, jelly fig polysaccharide/pullulan and chitosan/pullulan have been incorporated with different types of drug molecules including ornidazole, amlodipine besylate/valsartan, paracetamol/caffeine, phloretin, moxifloxacin hydrochloride, repaglinide, ampicillin, aspirin, and so forth. In these respective reports, nonaqueous solvents, high stirring temperature (70 °C), or soluble salt derivates of drug molecules have been used to ensure the dissolution of both the polymer and drugs in the electrospinning solution system.…”